Argentina vs New Zealand: Number of isolates tested for extended-spectrum cephalosporins
Argentina
868
in 2018
New Zealand
456
in 2017
Argentina rank
6th
New Zealand rank
8th
Number of isolates tested for extended-spectrum cephalosporins over time
- Argentina
- New Zealand
How they compare
Argentina currently reports 868 against 456 in New Zealand, a difference of 412.
That makes Argentina's figure about 1.9 times New Zealand's.
Across all 9 years both countries report, Argentina has been ahead every year.
Argentina ranks 6th and New Zealand ranks 8th of 51 countries.
Argentina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 310 | 234 | 76 | Argentina |
| 2010s | 587 | 389.38 | 197.62 | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for extended-spectrum cephalosporins, Argentina or New Zealand?
- Argentina, at 868 against 456 in New Zealand as of 2018.
- What is the difference in number of isolates tested for extended-spectrum cephalosporins between Argentina and New Zealand?
- 412, with Argentina ahead.
- How many years of comparable data are there for Argentina and New Zealand?
- 9 years are reported by both, from 2009 to 2017.
- How do Argentina and New Zealand rank globally for number of isolates tested for extended-spectrum cephalosporins?
- Argentina ranks 6th and New Zealand ranks 8th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for extended-spectrum cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.